Answers are grounded in this paper and cite their sources.
Nowadays, epidemic of obesity become pandemic worldwide and both C/EBP and PPAR played a crucial role in adipogenesis, insulin sensitization, and glucose homeostasis and lipid metabolism.The main objective of this computational study is to identify the drug like molecule, having antiadipogenesis properties and serve as potential inhibitor against C/EBP and PPAR.In the present study, molecular docking was performed by AutoDock Vina suit.A total of 148 flavonoid compounds were selected for the study and small molecule database created for virtual screening in order to find out new small drug like compound as potential antiadipogenesis agent.The crystal structure of C/EBP and PPAR was retrieved from protein data bank and their active sites were predicted and a nalyzed.Molecular docking was carried out and results showed tha t compounds epigallocatechin-3-gallate (EGCG), theaflavine and curcumin had good interaction with both the inhibitors.Further, toxicity analysis had been done and it was found that screened hits did not had any toxic effect, so screened phytochemicals can be used as potent target candidate drugs.The cu rrent in silic o study concludes tha t flavonoids deriva tives can potentia lly inhibit C/EBP and PPAR inhibitors and further in vitro and in vivo investigations confirmed its therapeutic potential.Perceptions after this study indicated that these novel phytochemicals could act as potentia l partial antagonist agents and serve a s new antiadipogenesis drug after fu rther investigation.
No takes yet. Share an insight, caveat, or question.
Saxena et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: